This review concluded that ultrasonography was more effective for erosion detection than X-ray and had a comparable efficacy to magnetic resonance imaging with good reproducibility. Inappropriate analysis and other limitations of the review and limitations of the available evidence mean that the conclusions and implications for practice should not be used to inform clinical decision making.
CRD commentary
The review addressed a clear question supported by reproducible inclusion criteria. Several relevant sources were searched, including sources for unpublished studies. The search was restricted by language. The search and eligibility were restricted to controlled trials but one of the included studies was a case report so it seemed that inclusion criteria were not applied consistently. It seemed that methods to reduce error and bias during the review process were not employed.
Despite the restriction to controlled trials, the authors used a quality assessment tool designed for diagnostic accuracy studies with no apparent adaptation of the tool. Only summary scores were presented for the quality assessment so it was unclear which study was subject to which bias and therefore the potential importance of that bias. It appeared that the studies in the meta-analyses were single-gate (diagnostic cohort) studies, which made the use of QUADAS appropriate. However, these studies were used subsequently as if they were RCTs, which was not appropriate. The pooled odds ratios for detection rates did not take into account whether the two tests detected erosion in the same or different patients and whether that detection was accurate, as the number of false positive and false negative results was unknown. The authors stated that only two of the included studies used the gold standard of computed tomography to confirm the diagnosis of erosion; the sensitivity for one of these studies was reported but it was unclear whether a reference standard was used in the other studies and if so, what this was. There was considerable clinical variation between the studies.
The authors' conclusion that the detection rate for ultrasonography was better than X-ray and comparable to MRI was correct but clinically uninformative without some indication of accuracy. Given the inappropriateness of the analysis conducted and other limitations of the review and the limitations of the available evidence, the conclusions and implications for practice should not be used to inform clinical decision making.
Implications of the review for practice and research
Practice: The authors stated that ultrasonography should be integrated into routine rheumatoid arthritis management, especially at disease onset. They also stated that because of the cost advantages over MRI, ultrasonography may be of particular interest for diagnosis and monitoring of structural changes in rheumatoid arthritis.
Research: The authors stated that further studies were needed to clarify whether ultrasonography erosions were comparable with X-ray erosions in detecting poor outcomes in patients with rheumatoid arthritis. They also stated that the specificity of ultrasonography for erosion detection and clinical significance of ultrasonography erosion should be studied in prospective trials to determine whether ultrasonography was a surrogate tool for early diagnosis of rheumatoid arthritis.
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